# Randomized Controlled Trial for Exparel Hip Fracture

> **NCT03289858** · PHASE4 · COMPLETED · sponsor: **University of Massachusetts, Worcester** · enrollment: 55 (actual)

## Conditions studied

- Hip Fractures

## Interventions

- **DRUG:** Exparel
- **DRUG:** Sodium Chloride

## Key facts

- **NCT ID:** NCT03289858
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2019-01-22
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03289858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03289858, "Randomized Controlled Trial for Exparel Hip Fracture". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03289858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*